Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Progress in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0079-6468(08)70081-XPMID 12516522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

  2004cited by this paper
• On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

  2000cited by this paper
• Role of Apoptosis Signal-Regulating Kinase in Regulation of the c-Jun N-Terminal Kinase Pathway and Apoptosis in Sympathetic Neurons

  2000cited by this paper
• Rescue of Hearing, Auditory Hair Cells, and Neurons by CEP-1347/KT7515, an Inhibitor of c-Jun N-Terminal Kinase Activation

  2000cited by this paper
• Apoptosis and neurologic disease.

  2000cited by this paper
• MPTP Activates c‐Jun NH2‐Terminal Kinase (JNK) and Its Upstream Regulatory Kinase MKK4 in Nigrostriatal Neurons In Vivo

  2000cited by this paper
• JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system.

  2000cited by this paper
• CEP‐1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria‐fornix lesion

  2000cited by this paper
• CEP‐1347 (KT7515), an Inhibitor of JNK Activation, Rescues Sympathetic Neurons and Neuronally Differentiated PC12 Cells from Death Evoked by three Distinct Insults

  1999cited by this paper
• Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death

  1999cited by this paper
• CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.

  1999cited by this paper
• Fas activates the JNK pathway in human colonic epithelial cells: lack of a direct role in apoptosis.

  1999cited by this paper
• The stress-activated protein kinase pathways

  1999cited by this paper
• Dopamine receptors--physiological understanding to therapeutic intervention potential.

  1999cited by this paper
• Characterization and time course of MPP+‐induced apoptosis in human SH‐SY5Y neuroblastoma cells

  1999cited by this paper
• Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

  1999cited by this paper
• Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures.

  1999cited by this paper
• The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

  1999cited by this paper
• Mitochondria in the etiology and pathogenesis of parkinson's disease

  1998cited by this paper
• Sealing one's fate: control of cell death in neurons.

  1998cited by this paper
• The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death.

  1998cited by this paper
• Phosphorylation of c-Jun Is Necessary for Apoptosis Induced by Survival Signal Withdrawal in Cerebellar Granule Neurons

  1998cited by this paper
• Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.

  1998cited by this paper
• CEP‐1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons

  1998cited by this paper
• Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis.

  1998cited by this paper
• Light deprivation accelerates recovery from frontal cortical neglect: relation to locomotion and striatal Fos expression.

  1998cited by this paper
• Lasting N-Terminal Phosphorylation of c-Jun and Activation of c-Jun N-Terminal Kinases after Neuronal Injury

  1998cited by this paper
• Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

  1998cited by this paper
• Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

  1998cited by this paper
• Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis.

  1998cited by this paper
• Human Mitogen-activated Protein Kinase Kinase 7 (MKK7) Is a Highly Conserved c-Jun N-terminal Kinase/Stress-activated Protein Kinase (JNK/SAPK) Activated by Environmental Stresses and Physiological Stimuli*

  1998cited by this paper
• Defective T cell differentiation in the absence of Jnk1.

  1998cited by this paper
• The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.

  1998cited by this paper
• Motoneuron Apoptosis Is Blocked by CEP-1347 (KT 7515), a Novel Inhibitor of the JNK Signaling Pathway

  1998cited by this paper
• Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress

  1998cited by this paper
• CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo.

  1998cited by this paper
• Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.

  1997cited by this paper
• Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene

  1997cited by this paper
• Nedd2 Is Required for Apoptosis after Trophic Factor Withdrawal, But Not Superoxide Dismutase (SOD1) Downregulation, in Sympathetic Neurons and PC12 Cells

  1997cited by this paper
• Strong c-Jun/AP-1 immunoreactivity is restricted to apoptotic cells following intracerebral ibotenic acid injection in developing rats.

  1997cited by this paper
• Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase

  1997cited by this paper
• Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.

  1997cited by this paper
• Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein

  1997cited by this paper
• Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.

  1997cited by this paper
• Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

  1997cited by this paper
• Identification of c-Jun NH2-terminal Protein Kinase (JNK)-activating Kinase 2 as an Activator of JNK but Not p38*

  1997cited by this paper
• In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

  1997cited by this paper
• SKK4, a novel activator of stress‐activated protein kinase‐1 (SAPK1/JNK)

  1997cited by this paper
• Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives.

  1997cited by this paper
• Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis

  1997cited by this paper
• Mechanisms of neuronal degeneration: a final common pathway?

  1997cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997cited by this paper
• Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.

  1996cited by this paper
• Origin and functional consequences of the complex I defect in Parkinson's disease

  1996cited by this paper
• The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation.

  1996cited by this paper
• Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.

  1996cited by this paper
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death

  1996cited by this paper
• DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay

  1996cited by this paper
• The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat.

  1996cited by this paper
• Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity.

  1996cited by this paper
• Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density.

  1996cited by this paper
• Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity.

  1996cited by this paper
• Programmed cell death in the absence of c-Fos and c-Jun.

  1996cited by this paper
• Medial septal cholinergic neurons express c-Jun but do not undergo DNA fragmentation after fornix-fimbria transections.

  1996cited by this paper
• Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors

  1996cited by this paper
• The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation.

  1996cited by this paper
• Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein Kinase*

  1996cited by this paper
• The etiology of Parkinson's disease with emphasis on the MPTP story

  1996cited by this paper
• Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

  1996cited by this paper
• Neuronal Death in Developmental Models: Possible Implications in Neuropathology

  1996cited by this paper
• Signaling from the Small GTP-binding Proteins Rac1 and Cdc42 to the c-Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway

  1996cited by this paper
• Prediction of probable Alzheimer's disease in memory-impaired patients

  1996cited by this paper
• SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1

  1995cited by this paper
• Role of Mitogen-activated Protein Kinase Phosphatase during the Cellular Response to Genotoxic Stress

  1995cited by this paper
• K‐252a Promotes Survival and Choline Acetyltransferase Activity in Striatal and Basal Forebrain Neuronal Cultures

  1995cited by this paper
• A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death.

  1995cited by this paper
• Oxidative stress in Parkinson's disease

  1995cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.

  1995cited by this paper
• The rationale for the use of dopamine agonists in Parkinson's disease

  1995cited by this paper
• Evidence for apoptotic cell death in Alzheimer's disease.

  1995cited by this paper
• The effect of Pyrrolo[3,4-c]carbazole derivatives on spinal cord ChAT activity

  1995cited by this paper
• Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*)

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Transection of rat fimbria-fornix induces lasting expression of c-Jun protein in axotomized septal neurons immunonegative for choline acetyltransferase and nitric oxide synthase.

  1995cited by this paper
• Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1995cited by this paper
• K‐252a Induces Tyrosine Phosphorylation of the Focal Adhesion Kinase and Neurite Outgrowth in Human Neuroblastoma SH‐SY5Y Cells

  1995cited by this paper
• Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms

  1995cited by this paper
• Activation-induced apoptosis in lymphocytes.

  1994cited by this paper
• GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.

  1994cited by this paper
• A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.

  1994cited by this paper
• Induction of c-Jun and suppression of CREB transcription factor proteins in axotomized neurons of substantia nigra and covariation with tyrosine hydroxylase.

  1994cited by this paper
• Motoneurons deprived of trophic support in vitro require new gene expression to undergo programmed cell death.

  1994cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system.

  1994cited by this paper
• Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis

  1994cited by this paper
• The stress-activated protein kinase subfamily of c-Jun kinases

  1994cited by this paper
• Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun

  1994cited by this paper
• Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain.

  1994cited by this paper
• Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis.

  1994cited by this paper

• Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective

  2024cites this paper
• TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer

  2023cites this paper
• The emerging role of mixed lineage kinase 3 (MLK3) and its potential as a target for neurodegenerative diseases therapies.

  2023cites this paper
• Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure

  2020cites this paper
• Recent Advances in c-Jun N-terminal Kinase (JNK) Inhibitors.

  2020cites this paper
• Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure

  2020cites this paper
• Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation.

  2019cites this paper
• GW501516-activated PPARbeta/delta promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation

  2019cites this paper
• The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss.

  2019cites this paper
• Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.

  2019cites this paper
• Synergistic Inhibition of ERK1/2 and JNK, Not p38, Phosphorylation Ameliorates Neuronal Damages After Traumatic Brain Injury

  2018cites this paper
• Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development

  2017cites this paper
• Inhibiting Kinases in the CNS

  2017cites this paper
• Targeting JNK for the diagnosis and treatment of Alzheimer's disease

  2017cites this paper
• c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease

  2016influential citation
• RESTRICTION OF APOPTOSIS IN MATURE NEURONS BY MULTIPLE REDUNDANT BRAKES

  2016cites this paper
• Mixed - Lineage Protein kinases (MLKs) in inflammation, metabolism, and other disease states.

  2016cites this paper
• Neuropharmacologic Approaches to Restore the Brain’s Microenvironment

  2016cites this paper
• Targeting secret handshakes of biological processes for novel drug development

  2016cites this paper
• The interplay of JNK and SCG10 during cortical development and in excitotoxic responses in brain

  2014cites this paper
• Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders

  2014cites this paper
• Methylphenidate treatment affects mitogen-activated protein kinase activation in the striatum of young rats

  2013cites this paper
• Pharmacoresistance in Epilepsy

  2013cites this paper
• The Role of JNK Pathway in the Process of Excitotoxicity Induced by Epilepsy and Neurodegeneration

  2013cites this paper
• The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders

  2013cites this paper
• The role of the JNK/AP-1 pathway in the induction of iNOS and CATs in vascular cells

  2013cites this paper
• Inhibition of Phosphorylation of JNK Suppresses Aβ-Induced ER Stress and Upregulates Prosurvival Mitochondrial Proteins in Rat Hippocampus

  2013cites this paper
• Translating the therapeutic potential of neurotrophic factors to clinical 'proof of concept': a personal saga achieving a career-long quest.

  2012cites this paper
• GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation

  2012cites this paper
• Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.

  2012cites this paper
• ACS chemical neuroscience spotlight on CEP-1347.

  2011cites this paper
• Apoptotic mechanisms in the neonatal brain following hypoxia-ischemia

  2011cites this paper
• Milestones in movement disorders clinical trials: Advances and landmark studies

  2011cites this paper
• Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment.

  2011cites this paper
• Neurotrophic Factors as Novel Therapeutic Targets

  2011cites this paper
• Low Concentrations of Methamphetamine Can Protect Dopaminergic Cells against a Larger Oxidative Stress Injury: Mechanistic Study

  2011cites this paper
• Clinical neuroprotection in Parkinson's disease - still waiting for the breakthrough.

  2010cites this paper
• Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.

  2010cites this paper
• Targeting the undruggable proteome: the small molecules of my dreams.

  2010cites this paper
• Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: A therapeutic strategy based on modulation of mixed lineage kinase

  2010cites this paper
• Pathological roles of MAPK signaling pathways in human diseases.

  2010cites this paper
• Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

  2010cites this paper
• Targeting protein kinases in central nervous system disorders

  2009cites this paper
• Regioselective synthesis of 2‐methyl‐2,5,6,11,12,13‐hexahydro 4H indazolo[5,4‐a]pyrrolo[3,4‐c]carbazole‐4‐ones

  2009cites this paper
• Role of Mixed Lineage Kinase Inhibition in Neonatal Hypoxia-Ischemia

  2009influential citation
• Arctic Ground Squirrel (Spermophilus Parryii) Hippocampal Neurons Tolerate Prolonged Oxygen—Glucose Deprivation and Maintain Baseline ERK1/2 and JNK Activation Despite Drastic ATP Loss

  2008cites this paper
• Dual inhibitory roles of geldanamycin on the c-Jun NH2-terminal kinase 3 signal pathway through suppressing the expression of mixed-lineage kinase 3 and attenuating the activation of apoptosis signal-regulating kinase 1 via facilitating the activation of Akt in ischemic brain injury.

  2008cites this paper
• MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE

  2008cites this paper
• Rodent Toxin Models of PD: An Overview

  2008cites this paper
• Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

  2008cites this paper
• Antiapoptotic and Trophic Effects of Dominant-Negative Forms of Dual Leucine Zipper Kinase in Dopamine Neurons of the Substantia Nigra In Vivo

  2008cites this paper
• Animal Models of Parkinson's Disease to Aid Drug Discovery and Development

  2008cites this paper
• Functional models of Parkinson's disease: A valuable tool in the development of novel therapies

  2008cites this paper
• Metabolic stress signaling mediated by mixed-lineage kinases.

  2007cites this paper
• Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

  2007cites this paper
• Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

  2007influential citation
• Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3*

  2007cites this paper
• Chapter 21 – An Assessment of the Chances of Antiapoptotic Drug Therapy in Patients with Neurodegenerative Disorders

  2007cites this paper
• Kinase signaling pathways: potential therapeutic targets in Parkinson's disease

  2007cites this paper
• Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.

  2007cites this paper
• IME-COURSE OF c-Jun N-TERMINAL KINASE ACTIVATION AFTER EREBRAL ISCHEMIA AND EFFECT OF D-JNKI1 ON c-Jun AND ASPASE-3 ACTIVATION

  2007cites this paper
• Neuroprotective Therapy in Parkinson Disease

  2006cites this paper
• AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70.

  2006cites this paper
• Monocyte Activation Prevents HIV-1 Tat-Mediated Neurotoxicity Inhibition of Mixed Lineage Kinase 3

  2006cites this paper
• FlexNovo: Structure‐Based Searching in Large Fragment Spaces

  2006cites this paper
• Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation1

  2006cites this paper
• Regulation of axotomy‐induced dopaminergic neuron death and c‐Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase

  2006cites this paper
• Neuroprotection for Parkinson's disease.

  2006cites this paper
• Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis.

  2006cites this paper
• Down-regulation of the Mixed-lineage Dual Leucine Zipper-bearing Kinase by Heat Shock Protein 70 and Its Co-chaperone CHIP*

  2006cites this paper
• Mixed-Lineage Kinase Inhibitors Require the Activation of Trk Receptors to Maintain Long-Term Neuronal Trophism and Survival

  2005cites this paper
• Mixed lineage kinase–c‐jun N‐terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease

  2005cites this paper
• Inhibition of neuronal apoptosis by the cyclin‐dependent kinase inhibitor GW8510: Identification of 3′ substituted indolones as a scaffold for the development of neuroprotective drugs

  2005cites this paper
• The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

  2005cites this paper
• Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants

  2005cites this paper
• Tritiation of CEP‐1347 at high specific activity using several methods

  2005cites this paper
• Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway

  2005cites this paper
• Analysis of gene expression changes in a cellular model of Parkinson disease.

  2005cites this paper
• Knock‐down of POSH expression is neuroprotective through down‐regulating activation of the MLK3–MKK4–JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield

  2005cites this paper
• Complete Inhibition of Anisomycin and UV Radiation but Not Cytokine Induced JNK and p38 Activation by an Aryl-substituted Dihydropyrrolopyrazole Quinoline and Mixed Lineage Kinase 7 Small Interfering RNA*

  2005cites this paper
• Neurodegenerative Disorders: The Role of Genetic Factors in Their Origin and the Efficiency of Treatment

  2005cites this paper
• Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.

  2005cites this paper
• Mixed-lineage kinases: a target for the prevention of neurodegeneration.

  2004cites this paper
• Apoptosis and autoimmunity as proposed pathogenetic links between Helicobacter pylori infection and idiopathic achalasia.

  2004cites this paper
• Kinases with CEP-1347 LineageInflammation by Inhibition of Mixed Specific Modulation of Astrocyte

  2004cites this paper
• The c‐Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK‐ERK and Akt‐independent mechanism

  2004cites this paper
• Novel Agents for the Prevention of Breast Cancer: Targeting Transcription Factors and Signal Transduction Pathways

  2004cites this paper
• A non‐peptidyl neurotrophic small molecule for midbrain dopaminergic neurons

  2004cites this paper
• Hsp90/p50cdc37 Is Required for Mixed-lineage Kinase (MLK) 3 Signaling*

  2004cites this paper
• Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

  2004cites this paper
• Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer

  2004influential citation
• Clinical trials of neuroprotection for Parkinson’s disease

  2004cites this paper
• Specific Modulation of Astrocyte Inflammation by Inhibition of Mixed Lineage Kinases with CEP-13471

  2004cites this paper
• Reverse Two-hybrid Screening Identifies Residues of JNK Required for Interaction with the Kinase Interaction Motif of JNK-interacting Protein-1*

  2004cites this paper
• The Critical Features and the Mechanism of Inhibition of a Kinase Interaction Motif-based Peptide Inhibitor of JNK*

  2004cites this paper
• Apoptosis Induced by p75NTR Overexpression Requires Jun Kinase-Dependent Phosphorylation of Bad

  2003cites this paper
• The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease

  2003cites this paper
• Synthesis and kinase inhibitory activity of 3'-(S)-epi-K-252a.

  2002cites this paper